Patterned CpG methylation of silenced B cell gene promoters in classical hodgkin lymphoma-derived and primary effusion lymphoma cell lines

Journal of Molecular Biology

Volumn 350, Issue 4, 2005, Pages 631-640

  Doerr, Jeanette R ^a   Malone, Cindy S ^a   Fike, Francesca M ^a   Gordon, Melinda S ^a   Soghomonian, Shahe V ^a   Thomas, Roman K ^b   Tao, Qian ^c   Murray, Paul G ^d   Diehl, Volker ^b   Teitell, Michael A ^a   Wall, Randolph ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF COLOGNE   (Germany)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Classical Hodgkin lymphoma; CpG DNA methylation; Gene reactivation; Gene silencing; Primary effusion lymphoma

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BISULFITE; LYMPHOCYTE RECEPTOR; LYMPHOCYTE SURFACE MARKER; TRANSCRIPTION FACTOR;

ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; GENE ACTIVATION; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC EPIGENESIS; GENOMICS; GERMINAL CENTER; HODGKIN DISEASE; HUMAN; HUMAN CELL; LYMPHOMA CELL; METHYLATION; PREDICTION; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; PROMOTER REGION; REED STERNBERG CELL; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; B CELL LYMPHOMA; DNA SEQUENCE; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; TUMOR CELL LINE;

OXALIS TUBEROSA;

B-LYMPHOCYTES; BASE SEQUENCE; CELL LINE, TUMOR; DNA METHYLATION; GENE SILENCING; HODGKIN DISEASE; HUMANS; LYMPHOMA, B-CELL; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); SEQUENCE ANALYSIS, DNA;

EID: 20544472803     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2005.05.032     Document Type: Article

References (33)

1. R. Kuppers, U. Klein, M.L. Hansmann, and K. Rajewsky Cellular origin of human B-cell lymphomas N. Engl. J. Med. 341 1999 1520 1529
2. V. Ascoli, and F. Lo-Coco Body cavity lymphoma Curr. Opin. Pulm. Med. 8 2002 317 322
3. R.K. Thomas, D. Re, J. Wolf, and V. Diehl Part I: Hodgkin's lymphoma-molecular biology of Hodgkin and Reed-Sternberg cells Lancet Oncol. 5 2004 11 18
4. R. Kuppers, I. Schwering, A. Brauninger, K. Rajewsky, and M.L. Hansmann Biology of Hodgkin's lymphoma Ann. Oncol. 13 2002 11 18
5. U. Klein, A. Gloghini, G. Gaidano, A. Chadburn, E. Cesarman, R. Dalla-Favera, and A. Carbone Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts Blood 101 2003 4115 4121
6. M. Arguello, M. Sgarbanti, E. Hernandez, Y. Mamane, S. Sharma, and M. Servant Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines Oncogene 22 2003 964 973
7. C.B. Hertel, X.G. Zhou, S.J. Hamilton-Dutoit, and S. Junker Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma Oncogene 21 2002 4908 4920
8. F. Jundt, K. Kley, I. Anagnostopoulos, K. Schulze Probsting, A. Greiner, and S. Mathas Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease Blood 99 2002 3060 3062
9. H. Stein, T. Marafioti, H.D. Foss, H. Laumen, M. Hummel, and I. Anagnostopoulos Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription Blood 97 2001 496 501
10. J. Theil, H. Laumen, T. Marafioti, M. Hummel, G. Lenz, T. Wirth, and H. Stein Defective octamer-dependent transcription is responsible for silenced immunoglobulin transcription in Reed-Sternberg cells Blood 97 2001 3191 3196
11. C.S. Malone, M.D. Miner, J.R. Doerr, J.P. Jackson, S.E. Jacobsen, R. Wall, and M. Teitell CmC(A/T)GG DNA methylation in mature B cell lymphoma gene silencing Proc. Natl Acad. Sci. USA 98 2001 10404 10409
12. H.G. Drexler, C.C. Uphoff, G. Gaidano, and A. Carbone Lymphoma cell lines: in vitro models for the study of HHV-8+ primary effusion lymphomas (body cavity-based lymphomas) Leukemia 12 1998 1507 1517
13. J. Wolf, U. Kapp, H. Bohlen, M. Kornacker, C. Schoch, and B. Stahl Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells Blood 87 8 1996 3418 3428
14. C.J. van Noesel, and R.A. van Lier Architecture of the human B-cell antigen receptors Blood 82 1993 363 373
15. C.S. Malone, and R. Wall Bob1 (OCA-B/OBF-1) differential transactivation of the B cell-specific B29 (Ig beta) and mb-1 (Ig alpha) promoters J. Immunol. 168 2002 3369 3375
16. M.A. Teitell OCA-B regulation of B-cell development and function Trends Immunol. 24 2003 546 553
17. J.W. Said, K.K. Hoyer, S.W. French, L. Rosenfelt, M. Garcia-Lloret, and P.J. Koh TCL1 oncogene expression in B cell subsets from lymphoid hyperplasia and distinct classes of B cell lymphoma Lab. Invest. 81 2001 555 564
18. M. Teitell, M.A. Damore, G.G. Sulur, D.E. Turner, M.H. Stern, and J.W. Said TCL1 oncogene expression in AIDS-related lymphomas and lymphoid tissues Proc. Natl Acad Sci. USA 96 1999 9809 9814
19. R. Juttermann, E. Li, and R. Jaenisch Toxicity of 5-aza-2′- deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation Proc. Natl Acad. Sci. USA 91 1994 11797 11801
20. M. Yoshida, M. Kijima, M. Akita, and T. Beppu Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A J. Biol. Chem. 265 1990 17174 17179
21. P. Akerblad, M. Rosberg, T. Leanderson, and M. Sigvardsson The B29 (immunoglobulin beta-chain) gene is a genetic target for early B-cell factor Mol. Cell. Biol. 19 1999 392 401
22. S.A. Omori, and R. Wall Multiple motifs regulate the B-cell-specific promoter of the B29 gene Proc. Natl Acad. Sci. USA 90 1993 11723 11727
23. A.A. Thompson, W.J. Wood Jr, M.J. Gilly, M.A. Damore, S.A. Omori, and R. Wall The promoter and 5′ flanking sequences controlling human B29 gene expression Blood 87 1996 666 673
24. S.W. French, C.S. Malone, R.R. Shen, M. Renard, S.E. Henson, and M.D. Miner Sp1 transactivation of the TCL1 oncogene J. Biol. Chem. 278 2003 948 955
25. A. Ushmorov, O. Ritz, M. Hummel, F. Leithauser, P. Moller, H. Stein, and T. Wirth Epigenetic silencing of the immunoglubulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglubulin expression Blood 104 2004 3326 3334
26. M. Brandeis, D. Frank, I. Keshet, Z. Siegfried, M. Mendelsohn, and A. Nemes Sp1 elements protect a CpG island from de novo methylation Nature 371 1994 435 438
27. D. Macleod, J. Charlton, J. Mullins, and A.P. Bird Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island Genes Dev. 8 1994 2282 2292
28. S. Stevens, L. Wang, and R.G. Roeder Functional analysis of the OCA-B promoter J. Immunol. 164 2000 6372 6379
29. S.M. Iguchi-Ariga, and W. Schaffner CpG methylation of the cAMP-responsive enhancer/promoter sequence TGACGTCA abolishes specific factor binding as well as transcriptional activation Genes Dev. 3 1989 612 619
30. K. Rajewsky Clonal selection and learning in the antibody system Nature 381 1996 751 758
31. S.A. Keller, E.J. Schattner, and E. Cesarman Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells Blood 96 2000 2537 2542
32. S.J. Clark, and J. Melki DNA methylation and gene silencing in cancer: which is the guilty party? Oncogene 21 2002 5380 5387
33. S.J. Clark, J. Harrison, C.L. Paul, and M. Frommer High sensitivity mapping of methylated cytosines Nucl. Acids Res. 22 1994 2990 2997